AI assistant
Kosmos Energy Ltd. — Director's Dealing 2021
Jun 11, 2021
10514_mrq_2021-06-11_8346a403-a0bb-49aa-aed9-41406ab70fb0.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 5614B
Kosmos Energy Limited
11 June 2021
Kosmos Energy Ltd (the "Company")
PDMR Shareholding
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
11 June 2021
The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:
| PDMR | Date of transaction | No. of shares vested | No. of shares granted | No. of shares sold or withheld |
| Lisa A. Davis | 9 June 2021 | 0 | 51,830 | 0 |
| Sir Richard Dearlove | 9 June 2021 | 0 | 51,830 | 0 |
| Roy A. Franklin | 9 June 2021 | 0 | 51,830 | 0 |
| Deanna L. Goodwin | 9 June 2021 | 0 | 51,830 | 0 |
| Adebayo O. Ogunlesi | 9 June 2021 | 0 | 51,830 | 0 |
| Steven M. Sterin | 9 June 2021 | 0 | 51,830 | 0 |
The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.
This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.
Josh R. Marion
Vice President and Assistant Secretary
CONTACT:
Investor Relations
Jamie Buckland
+44 203 954 2831
Media Relations
Thomas Golembeski
+1-214-445-9674
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Lisa A. Davis |
| b) | Position / status | Director |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Shares, par value $0.01 per share |
| b) | Nature of the transactions | 51,830 restricted share units granted to the reporting person on June 9, 2021 under the Company's Long Term Incentive Plan and are scheduled to vest 100% on the earlier of June 9, 2022 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. |
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| f) | Date of the transactions | 9 June 2021 |
| g) | Place of the transaction | NYSE |
| 1. | Details of PDMR / person closely associated with them ("PCA") | ||
| a) | Name | Sir Richard Dearlove | |
| b) | Position / status | Director | |
| c) | Initial notification / amendment | Initial notification | |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument | Common Shares, par value $0.01 per share | |
| b) | Nature of the transactions | 51,830 restricted share units granted to the reporting person on June 9, 2021 under the Company's Long Term Incentive Plan and are scheduled to vest 100% on the earlier of June 9, 2022 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. | |
| Shares granted or vested | |||
| c) | Currency | USD | |
| Price | 3.28 | ||
| Volume | 51,830 | ||
| Total | 170,002.4 | ||
| Shares sold or withheld | |||
| d) | Currency | USD | |
| Price | 0 | ||
| Volume | 0 | ||
| Total | 0 | ||
| e) | Aggregated information | ||
| Price | USD | ||
| Volume | 3.28 | ||
| Total | 51,830 | ||
| f) | Date of the transactions | 170,002.4 | |
| g) | Place of the transaction | NYSE |
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Roy A. Franklin |
| b) | Position / status | Director |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Shares, par value $0.01 per share |
| b) | Nature of the transactions | 51,830 restricted share units granted to the reporting person on June 9, 2021 under the Company's Long Term Incentive Plan and are scheduled to vest 100% on the earlier of June 9, 2022 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. |
| Shares granted or vested | ||
| c) | Currency | USD |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| f) | Date of the transactions | 9 June 2021 |
| g) | Place of the transaction | NYSE |
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Deanna L. Goodwin |
| b) | Position / status | Director |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Shares, par value $0.01 per share |
| b) | Nature of the transactions | 51,830 restricted share units granted to the reporting person on June 9, 2021 under the Company's Long Term Incentive Plan and are scheduled to vest 100% on the earlier of June 9, 2022 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. |
| Shares granted or vested | ||
| c) | Currency | USD |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| f) | Date of the transactions | 9 June 2021 |
| g) | Place of the transaction | NYSE |
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Adebayo O. Ogunlesi |
| b) | Position / status | Director |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Shares, par value $0.01 per share |
| b) | Nature of the transactions | 51,830 restricted share units granted to the reporting person on June 9, 2021 under the Company's Long Term Incentive Plan and are scheduled to vest 100% on the earlier of June 9, 2022 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. |
| Shares granted or vested | ||
| c) | Currency | USD |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| f) | Date of the transactions | 9 June 2021 |
| g) | Place of the transaction | NYSE |
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Steven M. Sterin |
| b) | Position / status | Director |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Shares, par value $0.01 per share |
| b) | Nature of the transactions | 51,830 restricted share units granted to the reporting person on June 9, 2021 under the Company's Long Term Incentive Plan and are scheduled to vest 100% on the earlier of June 9, 2022 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. |
| Shares granted or vested | ||
| c) | Currency | USD |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 3.28 | |
| Volume | 51,830 | |
| Total | 170,002.4 | |
| f) | Date of the transactions | 9 June 2021 |
| g) | Place of the transaction | NYSE |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSFDFUSEFSEEM